- Home
- OXLCO vs SBFM Comparison
OXLCO vs SBFM Comparison
Compare OXLCO & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXLCO
- SBFM
- Stock Information
- Founded
- OXLCO N/A
- SBFM 2006
- Country
- OXLCO United States
- SBFM United States
- Employees
- OXLCO N/A
- SBFM N/A
- Industry
- OXLCO Investment Managers
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- OXLCO Finance
- SBFM Health Care
- Exchange
- OXLCO Nasdaq
- SBFM Nasdaq
- Market Cap
- OXLCO N/A
- SBFM 4.9M
- IPO Year
- OXLCO N/A
- SBFM N/A
- Fundamental
- Price
- OXLCO $22.58
- SBFM $1.35
- Analyst Decision
- OXLCO
- SBFM Strong Buy
- Analyst Count
- OXLCO 0
- SBFM 1
- Target Price
- OXLCO N/A
- SBFM $15.00
- AVG Volume (30 Days)
- OXLCO N/A
- SBFM 4.2M
- Earning Date
- OXLCO N/A
- SBFM 05-19-2025
- Dividend Yield
- OXLCO N/A
- SBFM N/A
- EPS Growth
- OXLCO N/A
- SBFM N/A
- EPS
- OXLCO N/A
- SBFM N/A
- Revenue
- OXLCO N/A
- SBFM $34,874,283.00
- Revenue This Year
- OXLCO N/A
- SBFM $192.48
- Revenue Next Year
- OXLCO N/A
- SBFM N/A
- P/E Ratio
- OXLCO N/A
- SBFM N/A
- Revenue Growth
- OXLCO N/A
- SBFM 44.75
- 52 Week Low
- OXLCO N/A
- SBFM $1.17
- 52 Week High
- OXLCO N/A
- SBFM $33.60
- Technical
- Relative Strength Index (RSI)
- OXLCO 44.03
- SBFM 32.16
- Support Level
- OXLCO $22.28
- SBFM $1.17
- Resistance Level
- OXLCO $22.65
- SBFM $1.59
- Average True Range (ATR)
- OXLCO 0.07
- SBFM 0.32
- MACD
- OXLCO -0.01
- SBFM -0.01
- Stochastic Oscillator
- OXLCO 44.78
- SBFM 5.44
About OXLCO Oxford Lane Capital Corp. Preferred Stock Shares 6.00% Series 2029
Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize its portfolio's risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.